Are Single-Domain Antibodies Shaping the Future of Therapeutics?
As viruses mutate at breakneck speed, traditional antibody therapies are often caught in a game of catch-up. But a recent breakthrough published in Nature Communications (May 2025) might just tip the scales. Scientists revealed a set of single-domain antibodies (sdAbs) capable of neutralizing both SARS-CoV-1 and SARS-CoV-2 with unprecedented potency. These sdAbs are not just more...
0 Comments 0 Shares 4 Views 0 Reviews